Tolou-Ghamari Zahra
Deputy of Research and Technology, Nutrition and Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Curr Drug Metab. 2025;25(8):547-553. doi: 10.2174/0113892002328742241210102522.
The well-established calcineurin inhibitor, tacrolimus, as an immunosuppressive agent, is widely prescribed after organ transplantation. Cytochrome P450 (CYP 450) isoforms are responsible for the metabolism of many features associated with food parameters like phytochemicals, juices, and fruits. This review article summarizes the findings of previous studies to help predict the efficacy or side effects of tacrolimus in the presence of food variables. From the commencement of databases associated with the topic of interest to 26 October 2024, all relevant articles were searched through PubMed, Scopus, and Web of Science. The suggested therapeutic range for tacrolimus trough concentration (C ) was reported as 5-15 ng/ml blood. Tacrolimus interaction with food variables could significantly change C after organ transplantation. For example, grapefruit juice could increase tacrolimus C due to CYP enzyme inhibition. Toxicity such as nephrotoxicity could result from turmeric and other herbal or food products. By inhibiting tacrolimus-metabolizing enzymes and transporters, a high intake of vegetables could increase the risk of adverse effects. Secondary metabolites of vegetables could lead to toxicity in patients with tacrolimus. Furthermore, grapefruit juice, citrus fruits, turmeric, and pomegranate juice could change clinical pharmacokinetics parameters such as T, C, AUC, and C of tacrolimus after organ transplantation. Bioavailability of tacrolimus might be decreased by induction of the CYP450 system and P-gp efflux pump due to cranberry, rooibos tea, and boldo. Increased inhibitory effect on CYP450 system and/or P-gp efflux pump by grapefruit juice, schisandra, berberine, turmeric, pomegranate juice, pomelo, and ginger could increase bioavailability of tacrolimus. A vigilant immunosuppressive strategy accompanied by scheduled therapeutic drug monitoring is recommended before and after transplant surgery.
成熟的钙调神经磷酸酶抑制剂他克莫司作为一种免疫抑制剂,在器官移植后被广泛应用。细胞色素P450(CYP 450)同工酶负责许多与食物参数相关特征的代谢,如植物化学物质、果汁和水果。这篇综述文章总结了先前研究的结果,以帮助预测在存在食物变量的情况下他克莫司的疗效或副作用。从与感兴趣主题相关的数据库建立之初到2024年10月26日,通过PubMed、Scopus和科学网搜索了所有相关文章。他克莫司谷浓度(C)的建议治疗范围报告为血液中5-15 ng/ml。器官移植后,他克莫司与食物变量的相互作用可能会显著改变C。例如,葡萄柚汁由于抑制CYP酶可增加他克莫司C。姜黄和其他草药或食品可能导致肾毒性等毒性。大量摄入蔬菜会抑制他克莫司代谢酶和转运蛋白,增加不良反应风险。蔬菜的次生代谢产物可能导致使用他克莫司的患者出现毒性。此外,葡萄柚汁、柑橘类水果、姜黄和石榴汁可改变器官移植后他克莫司的临床药代动力学参数,如T、C、AUC和C。蔓越莓、路易波士茶和波尔多叶因诱导CYP450系统和P-糖蛋白外排泵,可能会降低他克莫司的生物利用度。葡萄柚汁、五味子、黄连素、姜黄、石榴汁、柚子和生姜对CYP450系统和/或P-糖蛋白外排泵的抑制作用增强,可能会提高他克莫司的生物利用度。建议在移植手术前后采取谨慎的免疫抑制策略,并定期进行治疗药物监测。